ISSN: 1734-1922
Archives of Medical Science Special Issues
Current issue Archive Archives of Medical Science
Search
2/2009
 
Share:
Send email
Share:
abstract:

Invited review
Cannabinoids and cardiometabolic risk

Csaba Farsang
,
Zoltán Járai

Arch Med Sci 2009; 5, 2A: S 273– S 281
Online publish date: 2009/08/04
View full text Get citation
 
The regulatory role of the endocannabinoid system has been implicated in many physiological and pathological functions and as a consequence the modulation of function of this system has become a therapeutic target in various diseases and pathological states. The authors give an overview of the pharmacological background of the endocannabinoid system and a short summary of the most important preclinical data. The connection between the endocannabinoid system and cardiometabolic risk is also discussed. Finally, landmark human studies with the cannabinoid antagonist rimonabant – such as the RIO, SERENADE, ARPEGGIO, STRADIVARIUS and ADAGIO-LIPIDS studies – are also reviewed.
keywords:

endocannabinoid system, cardiometabolic risk, rimonabant, energy balance
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.